Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2003
06/11/2003EP1317258A2 Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease
06/11/2003EP1317186A1 Improved bioactive whey protein hydrolysate
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP1011683A4 Vitamin d analogues and their neuronal effects
06/11/2003EP0973741B1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist
06/11/2003EP0966462B1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
06/11/2003EP0892787B1 Novel alpha-hydroxylic acid derivatives, their production and use
06/11/2003EP0848755B1 Vegf-related protein
06/11/2003CN1423704A Process for producing tripeptides
06/11/2003CN1423649A Sulfonyl oxazole amines and their use as 5-HT6 receptor ligand
06/11/2003CN1423647A Beta-alanine derivatives and their use as receptor antagonists
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423645A 维他命d类似物 Vitamin d analogues
06/11/2003CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions
06/11/2003CN1423627A 维生素d类似物 Vitamin d analogues
06/11/2003CN1423558A Novel processes for preparing torsemide intermediate
06/11/2003CN1423557A Intracorporeal medicaments for photodynamic treatment of disease
06/11/2003CN1422950A Recombinant gland-related virus expressing human blood angiotonin II receptor I antisense gene and preparation method thereof
06/11/2003CN1422664A Compound preparation of root of red-rooted salvia for treating cerebrovascular and cardiovascular diseases and preparation method thereof
06/11/2003CN1422661A Chinese medicinal proprietary for treating hemiplegic by apoplexia-Fuzhengpiantanwan
06/11/2003CN1422659A Musk slow-controlled release preparation and preparation method thereof
06/11/2003CN1422653A Effective part of root of red-rooted salvia and compound powder injecta of root of red-rooted salvia and preparation method and use of said medicine
06/11/2003CN1422649A Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease
06/11/2003CN1422625A Medicine for treating congenital heart disease and its preparation method thereof
06/11/2003CN1422616A Use of hydroxy saflor yellow pigment A in preparing medicine for treating and preventing cardiovascular and cerebrovascular disease
06/11/2003CN1111057C Angitis treating medicine
06/11/2003CN1111054C Medicine for treating apoplexy and its preparing process
06/11/2003CN1111049C Medicine for curing angitis and its preparing method
06/11/2003CN1111047C Cassia seed tea and its preparing process
06/11/2003CN1111042C Medicine for treating cardiac and cerebral vascular diseases and its preparation
06/11/2003CN1111039C Chinese medicine for preventing and curing cardiac and cerebral vascular diseases
06/10/2003US6576762 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
06/10/2003US6576671 Left ventricular dysfunction; 5,6-dihydroxy- or 5,6-diiso-butyroloxy-2-methylaminotetralin
06/10/2003US6576653 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
06/10/2003US6576652 Administering substituted imidazoles, particular by losartan potassium, treatment of post-transplant hypertension.
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576645 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
06/10/2003US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
06/10/2003US6576637 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations,
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003US6576628 Matrix metalloprotease inhibitors; arthritis, corneal ulcers, arteriosclerosis
06/10/2003US6576619 Orally active A1 adenosine receptor agonists
06/10/2003US6576613 Title inhibitors of urokinase
06/10/2003US6576609 Methods and compositions for generating angiostatin
06/10/2003US6576608 Stimulating tyrosine phosphorylation of Flt4 tyrosine kinase receptor in Flt4-expressing cell
06/10/2003US6576260 Sustained-release form of administration containing tramadol saccharinate
06/10/2003CA2413024A1 Antipyretic preparation containing xylitol
06/10/2003CA2265708C Lipoxin compounds and their use in treating cell proliferative disorders
06/10/2003CA2232775C Acyl compounds
06/10/2003CA2216277C Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance
06/10/2003CA2093510C Oxysulfonyl carbamates
06/10/2003CA2054619C Aminocoumaran derivatives, their production and use
06/10/2003CA2040489C 4-¬3-(4-oxothiazoldinyl)|butynylamines, a process for their preparation and their use as medicaments
06/09/2003WO2003002536A1 Unsymmetrical cyclic diamine compound
06/06/2003CA2436943A1 Hydantoin compounds useful as anti-inflammatory agents
06/06/2003CA2413479A1 Kit for reducing aching
06/05/2003WO2003046574A2 Complement c3 precursor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046556A2 Globin biopolymer markers indicative of insulin resistance
06/05/2003WO2003046204A2 Humanized collagen antibodies and related methods
06/05/2003WO2003046164A1 Regulation of human prolyl 4-hydroxylase
06/05/2003WO2003046141A2 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
06/05/2003WO2003046012A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation
06/05/2003WO2003046011A1 Antigen presenting cell targeting conjugate an antigen presenting cell contacted with such conjugate their use for vaccination or as medicament and methods for their production or generation
06/05/2003WO2003046010A1 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
06/05/2003WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
06/05/2003WO2003045984A2 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
06/05/2003WO2003045983A1 Apolipoprotein biopolymer markers predictive of type ii diabetes
06/05/2003WO2003045981A2 Concentrating aqueous fractions of lisinopril by reverse osmosis
06/05/2003WO2003045974A2 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003WO2003045967A1 Aryl fused azapolycyclic compounds
06/05/2003WO2003045951A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003WO2003045950A1 Pyrazolopyridine derivtives and their pharmaceutical use
06/05/2003WO2003045949A1 Pyrazolopyridine derivatives
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045930A1 Therapeutic compounds
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045918A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
06/05/2003WO2003045913A1 Benzamide derivatives, processes for their preparation, and their pharmaceutical use
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003WO2003045908A2 Method for controlling angiogenesis in animals
06/05/2003WO2003045905A1 Hydroperylene derivatives
06/05/2003WO2003045902A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/05/2003WO2003045582A1 Metallic structures incorporating bioactive materials and methods for creating the same
06/05/2003WO2003045523A2 Therapeutic coating for an intravascular implant
06/05/2003WO2003045437A1 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
06/05/2003WO2003045433A1 Remedies for heart failure
06/05/2003WO2003045424A1 Methods of compositions for normalizing lipid levels in mammalian tissues
06/05/2003WO2003045420A2 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
06/05/2003WO2003045407A1 A pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof
06/05/2003WO2003045406A1 An chinese medicinal formulation treating stomachache, rib-side pain, headache and menstrual pain
06/05/2003WO2003045404A2 Treatment and diagnosis of diseases associated with adverse levels of zinc, cadmium and calcium
06/05/2003WO2003045394A1 Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
06/05/2003WO2003045388A1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
06/05/2003WO2003045386A1 Benzothiazole derivatives
06/05/2003WO2003045385A1 Benzothiazole derivatives
06/05/2003WO2003045384A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/05/2003WO2003045382A1 Therapeutic compounds for treating dyslipidemic conditions
06/05/2003WO2003045379A1 Hydrazonopyrazole derivatives and their use as therapeutics
1 ... 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 ... 1595